United States · Bill · HR
H.R. 2026 (115th)
Pharmaceutical Information Exchange Act
Introduced
6 April 2017
Last action
—
Status
Forwarded by Subcommittee to Full Committee (Amended) by the Yeas and Nays: 18 - 14 .
Sponsors
—
Subjects
Discovery layer
Source updated
11 August 2025
Summary
Pharmaceutical Information Exchange Act This bill amends the Federal Food, Drug, and Cosmetic Act to allow information about a new investigational medication or the investigational use of a medication approved by the Food and Drug Administration to be provided to health care entities if the information is based on reliable scientific evidence.
This text is taken from the official record. PoliticalRepo does not editorialize.
Timeline
No timeline events have been ingested for this record yet.
Votes
No vote records are attached yet.
Versions
No version snapshots stored. Document URLs remain at the source.
Documents
3 official files
Introduced in House (text)
Introduced in House (text)
Introduced in House · EN · 6 April 2017
Introduced in House (PDF)
Introduced in House · EN · 6 April 2017
Introduced in House
summary · EN · 6 April 2017
Sponsors
No sponsors or actors listed by the source.
Related records
No cross-record relationships stored yet.
Sources
PoliticalRepo is an index and interpretation layer, not the authoritative legal source.
- Official source: https://www.congress.gov/bill/115th-congress/house-bill/2026
- Open data entity: https://api.congress.gov/v3/bill/115/hr/2026